Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.
about
Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acidsThree new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancyRare Late-Onset Presentation of Glutaric Aciduria Type I in a 16-Year-Old Woman with a Novel GCDH Mutation.Neonatal astrocyte damage is sufficient to trigger progressive striatal degeneration in a rat model of glutaric acidemia-I.New frontiers in neuroimaging applications to inborn errors of metabolism.Wernicke-like encephalopathy during classic maple syrup urine disease decompensation.Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuriaMetabolic causes of epileptic encephalopathyCobalamin C defect: natural history, pathophysiology, and treatment.Mitochondrial acetoacetyl-CoA thiolase deficiency: basal ganglia impairment may occur independently of ketoacidosis.Oxidative Stress, Disrupted Energy Metabolism, and Altered Signaling Pathways in Glutaryl-CoA Dehydrogenase Knockout Mice: Potential Implications of Quinolinic Acid Toxicity in the Neuropathology of Glutaric Acidemia Type I.Toxic Synergism Between Quinolinic Acid and Glutaric Acid in Neuronal Cells Is Mediated by Oxidative Stress: Insights to a New Toxic Model.Propionic acidemia associated with visual hallucinations.Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy.Altered Redox Homeostasis in Branched-Chain Amino Acid Disorders, Organic Acidurias, and Homocystinuria.
P2860
Q24645084-48EE1CCE-86DD-4900-B901-238641076A7AQ27013643-229990F5-9BF3-4E10-8F47-A3FAC3317D89Q30416454-5232AB59-1E75-44D5-8348-9DA139977D58Q33941133-2A2D4A2D-9AC7-45D0-B7D6-C3F433CB1A44Q33967668-ACD9979C-477E-410C-A169-0394B9F84F3AQ34164768-0C85E706-5E1E-494F-8FB9-D3CD19EA1B6BQ36110718-AA029D6F-D680-4486-840F-BCA1FCEAEF93Q36908032-CD60538B-1188-49DE-8EA3-8464BBF4F868Q37772799-B4A377B9-F7C5-4E68-8E6A-1BADE6EB0D64Q38931837-F7A22AAD-7BE7-4730-B5DD-7ECEB060E94DQ40274773-833A2FF4-FEEB-470D-B7B9-E9C467FC7926Q46302938-C3CABC38-B146-418F-860F-94D667639FDAQ48788509-B67BCA41-B374-48FB-86BC-20B72986B8B8Q52690210-4854F98B-C989-4884-B3DC-84FDAF846B04Q54944181-B90AB2F8-EA05-453F-9108-63C54EC11BCE
P2860
Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.
@en
Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.
@nl
type
label
Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.
@en
Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.
@nl
prefLabel
Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.
@en
Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.
@nl
P2093
P2860
P1476
Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10545-008-0823-Z
P577
2008-04-04T00:00:00Z